-
India's Sindhu backs monkey measures as badminton worlds set to open
-
Hurricane Lala brushes past Hawaii's Big Island, bringing heavy rain
-
Mass drone attack on Moscow as Russian strikes kill three in Ukraine
-
'Something we dreamed of': Bangladesh celebrates historic cricket win
-
Djokovic feels the heat in Cincinnati defeat, Zverev wins all-nighter
-
Rain holds up India on day two of Sri Lanka Test
-
Pallister stuns Ledecky in Pan Pacs 800m free as two world records carry Douglass to gold
-
The Ukrainian social media channels tracking Russian missiles
-
Rampant Bangladesh make history with first-ever Test win in Australia
-
Disney offers fans an escapist bubble at D23 event
-
UK's media-savvy PM Burnham shifts messaging to TikTok, podcasts
-
Thousands await aid after deadly Indonesian quake
-
Gay badminton star Gilmour urges progress on LGBTQ rights in Asia
-
Chinese ship sets off for Europe through Arctic, halving travel time
-
Pallister takes down Ledecky in Pan Pacs 800m freestyle
-
Bangladesh on verge of historic win in Australia as Mehidy takes five
-
Douglass breaks 50m free world record again to claim Pan Pacs gold
-
Messi sees penalty saved as Nashville routs Inter Miami in MLS
-
As Opel turns to Chinese partners, its hometown frets about the future
-
Heat is on as German winegrowers struggle to protect vines
-
Mehidy takes three as Bangladesh close on historic win in Australia
-
Hope fades for finding survivors of Colombia quake as rescued woman dies
-
Hope fades for finding surivivors of Colombia quake as rescued woman dies
-
Japan aims for the moons of Mars
-
Hurricane Lala dumps heavy rain on Hawaii
-
'People could get hurt': Conservationists decry AI wildlife visuals
-
Jaded voters, same old choices: Brazil kicks off election campaign
-
'Another chance to live': Flores residents recall quake panic
-
'Everyone lives in fear': Yemenis worry about return to all-out war
-
Rivers among nine inducted into Basketball Hall of Fame
-
Cardinals' Baez bashes record three homers in MLB debut
-
No.1 Scheffler leads by two at PGA St. Jude playoff event
-
Djokovic feels the heat in Cincinnati opening defeat
-
Rennie confident Jordan, Roigard will be fit to face Springboks
-
Hunt bags third Euro gold, Diaz shines in triple jump
-
PSG sign Belgian winger Godts from Ajax
-
Depleted Djokovic falls in Cincinnati Masters opener
-
Nillessen claims shock European 1,500m gold
-
Lala, now a hurricane, dumps heavy rain on Hawaii
-
Taylor scores two tries in winning debut as New Zealand captain
-
American Kate Douglass reclaims 50m freestyle world record
-
England defender Spence leaves Spurs for Inter Milan
-
Kit confusion disrupts Newcastle friendly against Leverkusen
-
Moore double leads Spurs to 3-0 friendly win over Hoffenheim
-
Marchand wins first Euros gold as Liebmann breaks 1500m free world record
-
Man Utd beaten by former boss Amorim's AC Milan in friendly finale
-
Zambia's vote marred by intimidation, counting pause: observers
-
Villagers evacuate as Belgium battles record wildfire
-
Marchand wins 200m butterfly for first Euros gold
-
Despite booming economy, young Moroccans still dream of Europe
US greenlights pig kidney transplant trials
Two US biotech companies say the Food and Drug Administration has cleared them to conduct clinical trials of their gene-edited pig kidneys for human transplants.
United Therapeutics along with another company, eGenesis, have been working since 2021 on experiments implanting pig kidneys into humans: initially brain-dead patients and more recently living recipients.
Advocates hope the approach will help address the severe organ shortage. More than 100,000 people in the United States are awaiting transplants, including over 90,000 in need of kidneys.
United Therapeutics's approval, announced Monday, allows the company to advance its technology toward a licensed product if the trial succeeds.
The study authorization was hailed as a "significant step forward in our relentless mission to expand the availability of transplantable organs," by Leigh Peterson, the company's executive vice president.
The trial will initially enroll six patients with end-stage renal disease before expanding to as many as 50, United Therapeutics said in a statement. The first transplant is expected in mid-2025.
Meanwhile, rival eGenesis said it had received FDA approval in December for a separate three-patient kidney study.
"The study will evaluate patients with kidney failure who are listed for a transplant but who face a low probability of receiving a deceased donor offer within a five-year timeframe," the company said.
Xenotransplantation -- transplanting organs from one species to another -- has been a tantalizing yet elusive goal for science.
Early experiments in primates faltered, but advances in gene editing and immune system management have brought the field closer to reality.
Pigs have emerged as ideal donors: they grow quickly, produce large litters, and are already part of the human food supply.
United Therapeutics said trial patients would be monitored for life, assessing survival rates, kidney function, and the risk of zoonotic infections -- diseases that jump from animals to humans.
Currently, there is only one living human recipient of a pig organ: Towana Looney, a 53-year-old from Alabama who received a United Therapeutics kidney on November 25, 2024.
She is also the longest-surviving recipient, having lived with a pig kidney for 71 days as of Tuesday. David Bennett of Maryland received a pig heart in 2022 and survived 60 days.
M.A.Colin--AMWN